Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Risk-Stratification of Children Presenting to Ambulatory Paediatrics with First-Onset Seizures: Should We Order an Urgent CT Brain?

Brugman J, Solomons RS, Lombard C, Redfern A, Du Plessis AM.

J Trop Pediatr. 2019 Oct 18. pii: fmz071. doi: 10.1093/tropej/fmz071. [Epub ahead of print]

PMID:
31625577
2.

Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers.

Kretzmann JA, Evans CW, Moses C, Sorolla A, Kretzmann AL, Wang E, Ho D, Hackett MJ, Dessauvagie BF, Smith NM, Redfern AD, Waryah C, Norret M, Iyer KS, Blancafort P.

Chem Sci. 2019 Jun 27;10(33):7718-7727. doi: 10.1039/c9sc01432b. eCollection 2019 Sep 7.

3.

Effects of Grade and School Services on Children's Responsibility for Hearing Aid Care.

Klein KE, Spratford M, Redfern A, Walker EA.

Am J Audiol. 2019 Sep 13;28(3):673-685. doi: 10.1044/2019_AJA-19-0005. Epub 2019 Aug 20.

PMID:
31430182
4.

Medical registrar preparation course improves candidate confidence in key aspects of the medical registrar role.

Redfern A, Naeem M, Panchal R.

Clin Med (Lond). 2019 Jun;19(Suppl 3):40. doi: 10.7861/clinmedicine.19-3-s40. No abstract available.

5.

Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are Associated With Naturally Occurring, Insulin-Dependent Diabetes Mellitus in Dogs.

Jergens AE, Guard BC, Redfern A, Rossi G, Mochel JP, Pilla R, Chandra L, Seo YJ, Steiner JM, Lidbury J, Allenspach K, Suchodolski J.

Front Vet Sci. 2019 Jun 27;6:199. doi: 10.3389/fvets.2019.00199. eCollection 2019.

6.

Measuring height and weight as part of routine mammographic screening for breast cancer.

Darcey E, Ambati R, Lund H, Redfern A, Saunders C, Thompson S, Wylie E, Stone J.

J Med Screen. 2019 Jul 9:969141319860873. doi: 10.1177/0969141319860873. [Epub ahead of print] No abstract available.

PMID:
31288600
7.

Cost and cost-effectiveness of a parenting programme to prevent violence against adolescents in South Africa.

Redfern A, Cluver LD, Casale M, Steinert JI.

BMJ Glob Health. 2019 May 9;4(3):e001147. doi: 10.1136/bmjgh-2018-001147. eCollection 2019. Erratum in: BMJ Glob Health. 2019 May 28;4(3):e001147corr1.

8.

A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Shawky MS, Huo CW, Henderson MA, Redfern A, Britt K, Thompson EW.

Breast Cancer Res Treat. 2019 Sep;177(2):251-276. doi: 10.1007/s10549-019-05300-1. Epub 2019 Jun 8. Review.

PMID:
31177342
9.

Hypoxia as a signal for prison breakout in cancer.

Redfern A, Agarwal V, Thompson EW.

Curr Opin Clin Nutr Metab Care. 2019 Jul;22(4):250-263. doi: 10.1097/MCO.0000000000000577.

PMID:
31116106
10.

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides.

Sorolla A, Wang E, Clemons TD, Evans CW, Plani-Lam JH, Golden E, Dessauvagie B, Redfern AD, Swaminathan-Iyer K, Blancafort P.

Nanomedicine. 2019 Aug;20:102003. doi: 10.1016/j.nano.2019.04.006. Epub 2019 May 2.

11.

The association between mammographic density and breast cancer risk in Western Australian Aboriginal women.

Darcey E, Lloyd R, Cadby G, Pilkington L, Redfern A, Thompson SC, Saunders C, Wylie E, Stone J.

Breast Cancer Res Treat. 2019 Jul;176(1):235-242. doi: 10.1007/s10549-019-05225-9. Epub 2019 Apr 12.

PMID:
30977028
12.

Linear Mixed-Model Analysis to Examine Longitudinal Trajectories in Vocabulary Depth and Breadth in Children Who Are Hard of Hearing.

Walker EA, Redfern A, Oleson JJ.

J Speech Lang Hear Res. 2019 Mar 25;62(3):525-542. doi: 10.1044/2018_JSLHR-L-ASTM-18-0250.

PMID:
30950738
13.

Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).

Woodward N, De Boer RH, Redfern A, White M, Young J, Truman M, Beith J.

Clin Breast Cancer. 2019 Jun;19(3):216-224. doi: 10.1016/j.clbc.2019.02.008. Epub 2019 Feb 27.

PMID:
30922805
14.

The distribution and determinants of mammographic density measures in Western Australian aboriginal women.

McLean K, Darcey E, Cadby G, Lund H, Pilkington L, Redfern A, Thompson S, Saunders C, Wylie E, Stone J.

Breast Cancer Res. 2019 Feb 28;21(1):33. doi: 10.1186/s13058-019-1113-4.

15.

Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.

Hart NH, Galvão DA, Saunders C, Taaffe DR, Feeney KT, Spry NA, Tsoi D, Martin H, Chee R, Clay T, Redfern AD, Newton RU.

Trials. 2018 Dec 20;19(1):695. doi: 10.1186/s13063-018-3091-8.

16.

Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses.

Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J, Anderson C, Wang H, Norton R.

Hypertens Res. 2019 Feb;42(2):273-283. doi: 10.1038/s41440-018-0154-x. Epub 2018 Dec 6.

PMID:
30518984
17.

Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm.

Boyle F, Beith J, Burslem K, de Boer R, Hui R, Lim E, McCarthy N, Redfern A, Woodward N.

Asia Pac J Clin Oncol. 2018 Oct;14 Suppl 4:3-11. doi: 10.1111/ajco.13064.

PMID:
30288930
18.

Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer.

Lim E, Beith J, Boyle F, de Boer R, Hui R, McCarthy N, Redfern A, Wade T, Woodward N.

Asia Pac J Clin Oncol. 2018 Oct;14 Suppl 4:12-21. doi: 10.1111/ajco.13065.

PMID:
30288929
19.

The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Yeo B, Redfern AD, Mouchemore KA, Hamilton JA, Anderson RL.

Clin Exp Metastasis. 2018 Apr;35(4):255-267. doi: 10.1007/s10585-018-9917-7. Epub 2018 Jul 2. Review.

PMID:
29968171
20.

Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression.

Carboni L, Marchetti L, Lauria M, Gass P, Vollmayr B, Redfern A, Jones L, Razzoli M, Malki K, Begni V, Riva MA, Domenici E, Caberlotto L, Mathé AA.

Neuropsychopharmacology. 2018 Sep;43(10):2134-2145. doi: 10.1038/s41386-018-0117-6. Epub 2018 Jun 12.

21.

The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.

Redfern AD, Spalding LJ, Thompson EW.

Clin Exp Metastasis. 2018 Apr;35(4):285-308. doi: 10.1007/s10585-018-9906-x. Epub 2018 Jun 8. Review.

PMID:
29948647
22.

A randomized controlled trial of arthroscopic capsular release versus hydrodilatation in the treatment of primary frozen shoulder.

Gallacher S, Beazley JC, Evans J, Anaspure R, Silver D, Redfern A, Thomas W, Kitson J, Smith C.

J Shoulder Elbow Surg. 2018 Aug;27(8):1401-1406. doi: 10.1016/j.jse.2018.04.002. Epub 2018 May 22.

PMID:
29798823
23.

Representation of facial identity includes expression variability.

Redfern AS, Benton CP.

Vision Res. 2019 Apr;157:123-131. doi: 10.1016/j.visres.2018.05.004. Epub 2018 May 24.

24.

Parenting for Lifelong Health: a pragmatic cluster randomised controlled trial of a non-commercialised parenting programme for adolescents and their families in South Africa.

Cluver LD, Meinck F, Steinert JI, Shenderovich Y, Doubt J, Herrero Romero R, Lombard CJ, Redfern A, Ward CL, Tsoanyane S, Nzima D, Sibanda N, Wittesaele C, De Stone S, Boyes ME, Catanho R, Lachman JM, Salah N, Nocuza M, Gardner F.

BMJ Glob Health. 2018 Jan 31;3(1):e000539. doi: 10.1136/bmjgh-2017-000539. eCollection 2018.

25.

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial.

Gianni L, Mansutti M, Anton A, Calvo L, Bisagni G, Bermejo B, Semiglazov V, Thill M, Chacon JI, Chan A, Morales S, Alvarez I, Plazaola A, Zambetti M, Redfern AD, Dittrich C, Dent RA, Magazzù D, De Fato R, Valagussa P, Tusquets I.

JAMA Oncol. 2018 Mar 1;4(3):302-308. doi: 10.1001/jamaoncol.2017.4612.

26.

Heart failure following oncological treatment.

Marangou J, Redfern A, Haddad T, Rankin JM, Dwivedi G.

Curr Opin Cardiol. 2018 Mar;33(2):237-244. doi: 10.1097/HCO.0000000000000488. Review.

PMID:
29251671
27.

Expressive Faces Confuse Identity.

Redfern AS, Benton CP.

Iperception. 2017 Sep 19;8(5):2041669517731115. doi: 10.1177/2041669517731115. eCollection 2017 Sep-Oct.

28.

Role of the gastrointestinal microbiota in small animal health and disease.

Redfern A, Suchodolski J, Jergens A.

Vet Rec. 2017 Oct 7;181(14):370. doi: 10.1136/vr.103826. Epub 2017 Sep 15. Review.

PMID:
28916525
29.

Expression Dependence in the Perception of Facial Identity.

Redfern AS, Benton CP.

Iperception. 2017 Jun 1;8(3):2041669517710663. doi: 10.1177/2041669517710663. eCollection 2017 May-Jun.

30.

Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.

Hart NH, Newton RU, Spry NA, Taaffe DR, Chambers SK, Feeney KT, Joseph DJ, Redfern AD, Ferguson T, Galvão DA.

BMJ Open. 2017 May 30;7(5):e014458. doi: 10.1136/bmjopen-2016-014458.

31.

Seasonal variations in cardiovascular disease.

Stewart S, Keates AK, Redfern A, McMurray JJV.

Nat Rev Cardiol. 2017 Nov;14(11):654-664. doi: 10.1038/nrcardio.2017.76. Epub 2017 May 18. Review.

PMID:
28518176
32.

Perceived Duration Increases with Contrast, but Only a Little.

Benton CP, Redfern AS.

Front Psychol. 2016 Dec 15;7:1950. doi: 10.3389/fpsyg.2016.01950. eCollection 2016.

33.

Reducing child abuse amongst adolescents in low- and middle-income countries: A pre-post trial in South Africa.

Cluver L, Meinck F, Yakubovich A, Doubt J, Redfern A, Ward C, Salah N, De Stone S, Petersen T, Mpimpilashe P, Romero RH, Ncobo L, Lachman J, Tsoanyane S, Shenderovich Y, Loening H, Byrne J, Sherr L, Kaplan L, Gardner F.

BMC Public Health. 2016 Jul 13;16(1):567.

34.

Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.

Shawky MS, Martin H, Hugo HJ, Lloyd T, Britt KL, Redfern A, Thompson EW.

Oncotarget. 2017 Jan 17;8(3):5578-5591. doi: 10.18632/oncotarget.13484. Review.

35.

Primum non nocere: a case of a humeral fracture in a patient with fibrodysplasia progressiva ossificans.

Yewlett A, Kitson J, Redfern A, Smith C.

Shoulder Elbow. 2016 Jan;8(1):37-40. doi: 10.1177/1758573215598498. Epub 2015 Aug 10.

36.

A parenting programme to prevent abuse of adolescents in South Africa: study protocol for a randomised controlled trial.

Cluver L, Meinck F, Shenderovich Y, Ward CL, Romero RH, Redfern A, Lombard C, Doubt J, Steinert J, Catanho R, Wittesaele C, De Stone S, Salah N, Mpimpilashe P, Lachman J, Loening H, Gardner F, Blanc D, Nocuza M, Lechowicz M.

Trials. 2016 Jul 19;17(1):328. doi: 10.1186/s13063-016-1452-8.

37.

Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.

Redfern A, Burslem K, Woodward N, Beith J, McCarthy N, De Boer R, Bell R.

Asia Pac J Clin Oncol. 2016 Mar;12 Suppl 1:19-31. doi: 10.1111/ajco.12492. Review.

PMID:
27001209
38.

Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape.

Beith J, Burslem K, Bell R, Woodward N, McCarthy N, De Boer R, Loi S, Redfern A.

Asia Pac J Clin Oncol. 2016 Mar;12 Suppl 1:3-18. doi: 10.1111/ajco.12491. Review.

PMID:
27001208
39.

Children with disabling chronic conditions in the Western health subdistrict of Cape Town, South Africa: Estimating numbers and service gaps.

Redfern A, Westwood A, Donald KA.

S Afr Med J. 2016 Feb 22;106(3):302-7. doi: 10.7196/SAMJ.2016.v106i3.9825.

PMID:
26915947
40.

Inflammatory breast cancer: A decade of experience.

Do Nascimento VC, Rajan R, Redfern A, Saunders C.

Asia Pac J Clin Oncol. 2016 Sep;12(3):242-7. doi: 10.1111/ajco.12459. Epub 2016 Feb 22.

PMID:
26899402
41.

Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.

Taylor J, Dunkerley S, Silver D, Redfern A, Talbot N, Sharpe I, Guyver P.

Foot (Edinb). 2016 Mar;26:23-9. doi: 10.1016/j.foot.2015.08.007. Epub 2015 Aug 31.

PMID:
26802946
42.

Cancer services in Western Australia: A comparison of regional outcomes with metropolitan Perth.

Martin HL, Ohara K, Chin W, Davidson A, Bayliss E, Redfern A, Khattak MA.

Aust J Rural Health. 2015 Oct;23(5):302-8. doi: 10.1111/ajr.12218. Epub 2015 Aug 10.

PMID:
26257325
43.

Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.

Cursons J, Leuchowius KJ, Waltham M, Tomaskovic-Crook E, Foroutan M, Bracken CP, Redfern A, Crampin EJ, Street I, Davis MJ, Thompson EW.

Cell Commun Signal. 2015 May 15;13:26. doi: 10.1186/s12964-015-0106-x.

44.

Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.

McInnes LM, Jacobson N, Redfern A, Dowling A, Thompson EW, Saunders CM.

Front Oncol. 2015 Feb 26;5:42. doi: 10.3389/fonc.2015.00042. eCollection 2015. Review.

45.

Acute cardiomyopathy with MCAT abuse.

Redfern A, Sampson C, Giovannelli M.

J Intensive Care Soc. 2015 Feb;16(1):83-84. doi: 10.1177/1751143714556957. Epub 2015 Feb 17.

46.

An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.

Wressnigg N, van der Velden MV, Portsmouth D, Draxler W, O'Rourke M, Richmond P, Hall S, McBride WJ, Redfern A, Aaskov J, Barrett PN, Aichinger G.

Clin Vaccine Immunol. 2015 Mar;22(3):267-73. doi: 10.1128/CVI.00546-14. Epub 2014 Dec 24.

47.

Renal arcuate vein microthrombi-associated AKI.

Redfern A, Mahmoud H, McCulloch T, Shardlow A, Hall M, Byrne C, Selby NM.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):180-6. doi: 10.2215/CJN.01540214. Epub 2014 Dec 1.

48.

Evaluation of a novel nicotine inhaler device: part 1--arterial and venous pharmacokinetics.

Moyses C, Hearn A, Redfern A.

Nicotine Tob Res. 2015 Jan;17(1):18-25. doi: 10.1093/ntr/ntu228. Epub 2014 Nov 10.

49.

Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer.

Chan A, Shannon C, de Boer R, Baron-Hay S, Redfern A, Bauwens A, Craft P, Webb S, Townsend A, Kotasek D.

Asia Pac J Clin Oncol. 2014 Dec;10(4):368-75. doi: 10.1111/ajco.12292. Epub 2014 Oct 28.

PMID:
25351929
50.

Evaluation of a novel nicotine inhaler device: part 2--effect on craving and smoking urges.

Moyses C, Hearn A, Redfern A.

Nicotine Tob Res. 2015 Jan;17(1):26-33. doi: 10.1093/ntr/ntu122. Epub 2014 Jul 31.

Supplemental Content

Loading ...
Support Center